about
Plasmin cleaves the juxtamembrane domain and releases truncated species of the urokinase receptor (CD87) from human bronchial epithelial cells.Specific inhibition of thrombin-induced cell activation by the neutrophil proteinases elastase, cathepsin G, and proteinase 3: evidence for distinct cleavage sites within the aminoterminal domain of the thrombin receptor.Role of vegetation-associated protease activity in valve destruction in human infective endocarditis.Disruption of the endothelial barrier by proteases from the bacterial pathogen Pseudomonas aeruginosa: implication of matrilysis and receptor cleavageDiagnosis of Bernard-Soulier syndrome and Glanzmann's thrombasthenia with a monoclonal assay on whole blood.Surface modifications in the platelets of a patient with alpha-N-acetyl-D-galactosamine residues, the Tn-syndrome.Proteinase-activated receptor-2 and human lung epithelial cells: disarming by neutrophil serine proteinases.[The platelet fibrinogen receptor: a model for the analysis of cellular adhesion mechanisms and their modification in pathology]Neutrophil proteinase cathepsin G is proteolytically active on the human platelet glycoprotein Ib-IX receptor: characterization of the cleavage sites within the glycoprotein Ib alpha subunit.Studies on the interaction of platelet glycoprotein IIb-IIIa and glycoprotein IV with fibrinogen and thrombospondin: a new immunochemical approach.Activation of human pro-urokinase by unrelated proteases secreted by Pseudomonas aeruginosa.Human endoglin as a potential new partner involved in platelet-endothelium interactions.The thermolysin-like metalloproteinase and virulence factor LasB from pathogenic Pseudomonas aeruginosa induces anoikis of human vascular cells.The human airway trypsin-like protease modulates the urokinase receptor (uPAR, CD87) structure and functions.Alpha-granule pool of glycoprotein IIb-IIIa in normal and pathologic platelets and megakaryocytes.Analysis of the membrane glycoproteins of platelets in the Wiskott-Aldrich syndromePlatelet membrane glycoproteins and platelet functions during storage in the presence of a proteinase inhibitorActivation of the fibrinogen receptor on human platelets exposed to alpha chymotrypsin. Relationship with a major proteolytic cleavage at the carboxyterminus of the membrane glycoprotein IIb heavy chainA defect of platelet aggregation associated with an abnormal distribution of glycoprotein IIb-IIIa complexes within the platelet: the cause of a lifelong bleeding disorderIdentification of a normal human bone marrow cell population co-expressing megakaryocytic and erythroid markers in cultureComparative immunochemical analysis of membrane proteins from human platelets and endothelial cells[Platelet glycoprotein complex IIb-IIIa: a polyvalent membrane receptor?]Aggregation of chymotrypsin-treated thrombasthenic platelets is mediated by fibrinogen binding to glycoproteins IIb and IIIaTemperature-dependent effects of EDTA on the membrane glycoprotein IIb-IIIa complex and platelet aggregabilityFurther studies on the interaction between human platelet membrane glycoproteins IIb and IIIa in triton X-100The formation of Ca++-dependent complexes of platelet membrane glycoproteins IIb and IIIa in solution as determined by crossed immunoelectrophoresisCharacterization of human platelet glycoprotein antigens giving rise to individual immunoprecipitates in crossed-immunoelectrophoresisProteolysis of thrombospondin during cathepsin-G-induced platelet aggregation: functional role of the 165-kDa carboxy-terminal fragmentMembrane glycoprotein defects in congenital platelet disordersExposure of human platelets to plasmin results in the expression of irreversibly active fibrinogen receptorsHuman platelet antigen 3 (HPA-3): localization of the determinant of the alloantibody Lek(a) (HPA-3a) to the C-terminus of platelet glycoprotein IIb heavy chain and contribution of O-linked carbohydratesRegulation of the structure and activity of platelet adhesion receptors by leukocyte proteinasesBiochemistry and immunology of platelet membranes with reference to glycoprotein compositionThe human platelet membrane glycoprotein complex GP IIb-IIIa expresses antigenic sites not exposed on the dissociated glycoproteinsInteraction of AP-2, a monoclonal antibody specific for the human platelet glycoprotein IIb-IIIa complex, with intact plateletsTotal inhibition of phospholipase C and phosphatidylinositol 3-kinase by okadaic acid in thrombin-stimulated plateletsPhosphoinositide 3-kinase inhibition reverses platelet aggregation triggered by the combination of the neutrophil proteinases elastase and cathepsin G without impairing alpha(IIb)beta(3) integrin activationRelative importance of the glycoprotein Ib-binding domain and the RGD sequence of von Willebrand factor for its interaction with endothelial cellsHuman neutrophil cathepsin G down-regulates LPS-mediated monocyte activation through CD14 proteolysisOn the mechanism of plasmin-induced aggregation of human platelets: implication of secreted von Willebrand factor
P50
Q31110978-E4058A00-96BE-460F-9DFB-599135E3F105Q34418797-2F328B1F-1CA6-42DC-803A-F4A1F3A4E2A8Q34429820-938B8506-7A89-446B-BD70-4B6FD8CE6461Q34999718-087B85FF-310F-4D09-981A-D94AD4DC4609Q35203348-EA72C5C1-9C4F-42FA-A1D4-D9BC1589892FQ36988723-1D901D62-9C8E-4825-84E7-65967E4B60C9Q40669694-FED22B6E-EF50-4CE1-9EFE-97B26B36D678Q42005601-B5EBB767-8513-4998-BAD9-082FD36301BEQ42070244-C0D19E1D-BB44-4272-882D-694F57B37250Q42118815-19F20FD3-F945-40F1-847C-D5399485C0C2Q43118896-A5B74803-6809-42ED-A0DB-8E80C472FC21Q48109054-21022B36-E6D0-4EE6-8047-11571E211C75Q52610170-97D02A9E-922D-4DEB-A04B-0F5A84F895F8Q53576300-A7ACBD79-229C-47DE-A71C-196429237105Q54097821-0A71A241-4286-4C70-A065-B0E9DD9876A0Q59548387-D73E5A77-298B-4BC8-B1DB-71CACD19836AQ67699881-A84E426A-8D81-4278-B413-18F5B7BF6686Q67969586-E33B9024-14F4-4B79-80DA-52CAEA2A2BF9Q68222516-026B4369-2F0E-476B-A5B3-7A2BD0585BB6Q68235317-B42A1FD6-7F1F-4B1C-A5AC-73E73DF7DDD6Q68566143-3AB174D1-87BF-406F-9A05-D9B93B2875DDQ69037241-9C99DC06-49FF-48B2-B06F-9A6E724C1C72Q70110295-08366C2B-42BE-40BD-89BF-C1D845958D37Q70126417-6874BD83-7C7B-4B3C-BB23-3280504F7ABEQ70447620-5B0A97DC-779E-4003-B91F-3B54F0AE3E4EQ70549345-8F57EB78-E350-4BFE-8768-B41DB655D9D5Q70559859-C217AA03-88EC-4815-B6B8-A5C4A32B4B55Q71090374-761771D6-2BE6-4C8F-B7EA-5547A92BDF04Q71475865-15750C46-CB00-4C66-A81C-A2E4CA6511B2Q71575956-6BCB601E-FE81-4AD1-8300-3773F3788793Q72086109-054C5BCA-4481-4234-9CDC-B374DF747DF6Q72408222-E1C26A34-8489-4CD4-AAAD-91C8A5EC4756Q72643423-21F6DCA6-64D2-419E-9609-3DEA310E917AQ72749924-F243C730-ED6E-4432-8FD3-D6DD89503DC2Q72797414-A4CE60D9-23EA-4D64-BECC-B46A28969BB7Q73149502-E84044F5-C293-449C-8C88-547CEC682870Q73191359-599685DF-B756-4150-BBCB-5CC8CA44E1ADQ73732002-1FC7B61C-7F4D-4B94-820C-E1078523CA62Q74185346-952B0671-3346-48E8-9527-536CD97FDBABQ74764859-FABE928E-AA1E-4B2D-B7B9-350262C27D37
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Dominique Pidard
@ast
Dominique Pidard
@en
Dominique Pidard
@es
Dominique Pidard
@nl
Dominique Pidard
@sl
type
label
Dominique Pidard
@ast
Dominique Pidard
@en
Dominique Pidard
@es
Dominique Pidard
@nl
Dominique Pidard
@sl
prefLabel
Dominique Pidard
@ast
Dominique Pidard
@en
Dominique Pidard
@es
Dominique Pidard
@nl
Dominique Pidard
@sl
P106
P31
P496
0000-0002-5732-3279